Navigation Links
Biologics License Applications, Event Participations, and Stock Movements - Research Report on Baxter, WellPoint, Questcor Pharmaceuticals, CareFusion, and Hologic
Date:12/5/2013

NEW YORK, December 5, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Analysts' Corner announced new research reports highlighting Baxter International Inc. (NYSE: BAX), WellPoint Inc. (NYSE: WLP), Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), CareFusion Corporation (NYSE: CFN), and Hologic Inc. (NASDAQ: HOLX). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Baxter International Inc. Research Report

On December 2, 2013, Baxter International Inc. (Baxter), along with Halozyme Therapeutics, Inc. (Halozyme), announced that Baxter has completed submission of an amended biologics license application (BLA) to the US Food and Drug Administration (FDA) for re-initiating the review process for approval of HyQvia (Immune Globulin Infusion 10% (human) with Recombinant Human Hyaluronidase) facilitated subcutaneous infusion for the treatment of adults patients with primary immunodeficiency (PI). Baxter stated that the Company and Halozyme submitted additional preclinical data that was requested from the FDA in 2012, and are expecting a six-month review period. Commenting on the release, Ludwig Hantson, Ph.D., President of Baxter's BioScience business, stated, "We believe that if approved, HyQvia may become a valuable option for patients with immune deficiency as it allows for the delivery of a full dose of immunoglobulin often in a single site every three to four weeks, in the comfort of a patient's home." The
'/>"/>

SOURCE Analysts' Corner
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
2. Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
3. Avaxia Biologics is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation
4. CSL Behring Announces FDA Filing of Biologics License Application for 4-Factor PCC for Urgent Reversal of Vitamin K Antagonist Anticoagulant Therapy
5. Avaxia Biologics Announces Appointment of Michael D. Rivard as VP Corporate Development
6. Chinese Compulsory Immunization Program for Livestock Creates Massive Opportunity for Animal Vaccines and Biologics Developers
7. CMC Biologics Achieves Successful Pre-Approval European GMP Inspection by MHRA for Commercial Manufacturing
8. Pinnacle Biologics and INTERmedic Medical Devices announce strategic manufacturing and distribution agreement for cancer laser technology
9. CMC Biologics Acquires XOMAs Bay Area Manufacturing Facility
10. Global Spinal Devices and Biologics Market 2011-2015
11. Synthetic Biologics Reports Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... OAKS, Calif. and BRUSSELS ... AMGN ) and UCB (Euronext Brussels: UCB) ... (STudy evaluating effect of RomosozUmab Compared with Teriparatide ... for fracture pReviously treated with bisphosphonatE therapy). The ... statistically significant difference in favor of romosozumab in ...
(Date:9/1/2015)... Emerus Holdings, a national and innovative ... diagnostic care in partnership with leading health systems, ... to receive a strategic investment from Welsh, Carson, ... care investment firm. Emerus partners with ... and ambulatory clinical services to communities across a ...
(Date:9/1/2015)... 1, 2015  Edwards Lifesciences Corporation (NYSE: EW ... valves and hemodynamic monitoring, is scheduled to present at ... Hyatt Regency Boston in Boston, Massachusetts ... Michael A. Mussallem , Edwards Lifesciences, chief executive officer, ... a company discussion with conference attendees at 10:10 a.m. ...
Breaking Medicine Technology:Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 3Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 4Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 5Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 6Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 7Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 8Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 9Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 2Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 3
... at the Fourth Annual Medical Product Outsourcing (MPO) Symposium ... the outsourcing relationship with its "open-book pricing" roundtable discussion ... manufacturers are trying to limit cost by requiring suppliers ... director of marketing at Arc-Tronics. "The debate centers on ...
... Md., Oct. 19 The U.S. Food and ... for the prevention of stroke and blood clots ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... fibrillation, which affects more than 2 million Americans, ...
Cached Medicine Technology:MPO Symposium Panel Discussion to Address Open-Book Pricing and Its Effect on Long-Term Performance 2FDA Approves Pradaxa to Prevent Stroke in People With Atrial Fibrillation 2
(Date:9/1/2015)... ... September 01, 2015 , ... An August 25 ... plastic surgeries conducted each year on teenagers, quoting a New York City-area plastic ... Hills-based plastic surgeon Payam Jarrah-Nejad, M.D., F.I.C.S., F.A.C.S., known more familiarly to patients ...
(Date:9/1/2015)... ... 01, 2015 , ... The Capillus82™ has been cleared by ... in adults, announces Miami-based medical device manufacturer, Capillus, LLC. FDA clearance substantiates the ... when used at home to combat hair loss. , “Following the success ...
(Date:9/1/2015)... KY (PRWEB) , ... September 01, 2015 , ... ... practice physical therapy company, is pleased to announce their partnership with Apex ... merger allows both groups to continue to provide kind, compassionate, and empathetic care ...
(Date:9/1/2015)... NY (PRWEB) , ... September 01, 2015 , ... From ... 86 children and teenagers, from ages 6-18. Calvary’s Camp Compass® has taken place at ... staff included 65 adult counselors, some of whom work for Calvary, and two junior ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... prevent different malignancies. Some options for cancer treatment are available belonging to ... distinctive approach is necessary for effective treatment. Several molecules have been discovered ...
Breaking Medicine News(10 mins):Health News:Teen Plastic Surgery Article Understates the Most Important Realities of Procedures on Young People, Notes Dr. J 2Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 3Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 2Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 3
... Ore. Substance abuse increases among recent Hispanic immigrants ... of white Americans, according to new research presented today ... the American Sociological Associations Annual Meeting in New York. ... of which 1,690 persons identified themselves as Hispanic. It ...
... Aug. 13, 2007 UT Southwestern Medical Center researchers ... cocaine on the human cardiovascular system, including lowering the ... cocaine users. ,We have found that cocaines effects ... use of a drug called dexmedetomidine, which is currently ...
... visit to the family doctor includes a simple blood test to ... returns a worrisome result -- too many sticky brain proteins that ... 15 years -- a person could be offered an aspirin-like pill ... future a visionary team of researchers at Mayo Clinic’s campus in ...
... of cancer, conducted by researchers at the University of Southern ... method to identify the genetic changes that enable tumours to ... demonstrated in human breast and colorectal cancers, are significant to ... advancement of diagnostic tests and treatment for cancers. ...
... baby to be created from an egg matured in a ... Canada, researchers told a medical conference on Monday. ... with advanced ovarian disease, and three other women in the ... said. ,Doctors already collect and store eggs from ...
... popular among young teens, according to a new study. ... and above, but the study suggests that middle-school children play ... was conducted by a team of researchers led by Cheryl ... Mental Health and Media. ,As part of the ...
Cached Medicine News:Health News:Hispanic drug use rises in US culture 2Health News:New treatment effective in counteracting cocaine-induced symptoms 2Health News:A new century of Alzheimer's disease research 2Health News:A new century of Alzheimer's disease research 3Health News:A new century of Alzheimer's disease research 4Health News:A new century of Alzheimer's disease research 5Health News:A new century of Alzheimer's disease research 6Health News:A new century of Alzheimer's disease research 7Health News:A new century of Alzheimer's disease research 8Health News:A new century of Alzheimer's disease research 9Health News:A new century of Alzheimer's disease research 10Health News:A new century of Alzheimer's disease research 11Health News:A new century of Alzheimer's disease research 12Health News:A new century of Alzheimer's disease research 13Health News:A new century of Alzheimer's disease research 14Health News:A new century of Alzheimer's disease research 15Health News:A new century of Alzheimer's disease research 16Health News:A new century of Alzheimer's disease research 17Health News:Researchers Discover How Cancer Evades the Immune System 2Health News:Infertility Breakthrough With First Birth from Lab-matured Egg 2Health News:Infertility Breakthrough With First Birth from Lab-matured Egg 3Health News:M-rated Violent Video Games Most Popular Among Young Teens 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: